Original Research
Published on 07 Dec 2020
NOD2/RIG-I Activating Inarigivir Adjuvant Enhances the Efficacy of BCG Vaccine Against Tuberculosis in Mice
in Microbial Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2020.592333
- 8,969 views
- 22 citations
